ArticleCancer research and treatment2020

Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma.

Li Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.